Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
special purpose acquisition company
MedTech
Freenome to go public in $330M SPAC deal
Backed by an affiliate of Perceptive Advisors and joined by RA Capital, the move includes a commitment of $240 million in equity investments.
Conor Hale
Dec 5, 2025 10:35am
Singapore drug discovery platform heads to Nasdaq via SPAC deal
Oct 2, 2025 9:50am
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am
German cancer antibody biotech eyes SPAC as route to Nasdaq
Apr 23, 2025 6:09am
BridgeBio's cancer spinout backs SPAC as path to Nasdaq
Feb 28, 2025 9:25am
Medera plans SPAC merger to advance cardiac gene therapies
Sep 5, 2024 10:50am
